Oura Expands Healthcare Horizons with $625 Million Acquisition of Counsel Health
In a bold move to redefine personalized healthcare, Oura has announced its acquisition of the AI-driven primary care platform, Counsel Health, for a staggering $625 million. This strategic partnership comes on the heels of Oura postponing its ambitious IPO, originally valued at $2.2 billion, due to prevailing market uncertainties.
Merging Technology with Care
Oura, known for its innovative smart ring technology, has integrated Counsel Health’s chat-based medical services into its app since June. Users can now seamlessly receive tailored medical advice from Counsel’s AI and consult licensed physicians—all within the Oura ecosystem. This acquisition aims to broaden their collaborative efforts to enhance preventative, acute, specialty, and chronic care services.
Despite Oura’s strong hold on the smart ring market, emerging competitors like RingConn and Ultrahuman have begun to challenge its dominance. The acquisition of Counsel Health signals Oura’s commitment to innovation and expanding access to essential medical services.
Insights from Leadership
Oura CEO Tom Hale emphasized the complementary benefits of this acquisition: “Oura helps members understand their physiology, and with Counsel, users can actively manage their health—whether it’s answering quick questions, seeking prescriptions, or coordinating lab results and referrals.”
Counsel Health, which raised $25 million in a Series A funding round led by prominent investors like Andreessen Horowitz and GV last year, has successfully positioned itself as an AI-powered health platform. Post-acquisition, Counsel will continue providing services to both existing and new enterprise clients, aiming to broaden its AI healthcare model beyond Oura’s member base.
A Vision for the Future
Counsel Health’s CEO, Muthu Alagappan, will transition to Oura as the Chief Clinical AI Officer, bringing his team of 70 employees along. “Our foundation at Counsel is built on trust, safety, and responsibility, ensuring physicians remain integral to clinical decisions,” Alagappan stated. He added that Oura’s extensive data will enable clinicians to provide more informed care to users.
The acquisition is projected to finalize by the end of 2027, marking a significant milestone in Oura’s journey toward a more connected healthcare experience.
Stunning Growth Metrics
In financial news, Oura showcased remarkable growth with a 153% increase in revenue year-over-year, achieving $533 million for the quarter ending September 30. For FY 2026, the company reported an impressive revenue of around $1.75 billion, highlighting a 92% year-over-year growth trajectory. Oura’s valuation soared to $11 billion following a substantial $900 million funding round in October 2025.
As Oura pushes forward with this acquisition, it appears poised to not only enhance user engagement but also reshape the landscape of personalized healthcare.